10.08.19
Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), has completed the expansion of the company’s process development capabilities and laboratory space within its CDMO campus in Orange County, CA. To celebrate the launch of its newly expanded facilities, Avid is hosting an open house and laboratory tour for existing and prospective clients.
The completed expansion project further strengthens the company’s capabilities in the areas of R&D support, process development, process characterization and validation, and pilot scale production for a broad range of biotechnology products.
According to the company, the new suites accelerate its ability to develop and deliver cost-effective, robust, scalable and compliant processes and to drive efficient and rapid “on-boarding” of new customer programs progressing to manufacturing. Specific enhancements include a four-fold expansion of the company’s process development laboratory footprint and the addition of 24 advanced benchtop process development bioreactors, ranging from 3 liter to 15 liter capacity in single-use and glass.
“We are very excited to bring these state-of-the-art upstream and downstream process development laboratories online,” said Rick Hancock, interim president and chief executive officer, Avid Bioservices. “This represents another major milestone in positioning Avid at the top tier of biologics CDMOs and supports the ongoing expansion of our customer base, while providing additional capabilities for our current clients.”
The completed expansion project further strengthens the company’s capabilities in the areas of R&D support, process development, process characterization and validation, and pilot scale production for a broad range of biotechnology products.
According to the company, the new suites accelerate its ability to develop and deliver cost-effective, robust, scalable and compliant processes and to drive efficient and rapid “on-boarding” of new customer programs progressing to manufacturing. Specific enhancements include a four-fold expansion of the company’s process development laboratory footprint and the addition of 24 advanced benchtop process development bioreactors, ranging from 3 liter to 15 liter capacity in single-use and glass.
“We are very excited to bring these state-of-the-art upstream and downstream process development laboratories online,” said Rick Hancock, interim president and chief executive officer, Avid Bioservices. “This represents another major milestone in positioning Avid at the top tier of biologics CDMOs and supports the ongoing expansion of our customer base, while providing additional capabilities for our current clients.”
